New GMP Guideline for Biopharmaceutical and Biotech-Based Products
Published: 2005-01-21 06:59:00
Updated: 2005-01-21 06:59:00
The Korea Food and Drug Administration (KFDA) has recently completed a new administrative guideline for GMP (Good Manufacturing Practice) evaluation as specific to the domestic manufacturers of biopharmaceutical products, including vaccines and biotechnology-based treatments.
The KFDA expresse...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
